Summit Therapeutics Inc. Contingent Liabilities Recognised In Business Combination
Summit Therapeutics Inc. (SMMT) had Contingent Liabilities Recognised In Business Combination of GBP 80.00 thousand as of 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Notes
ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination · last filed 2020-06-02
- 2020-03-31: Contingent Liabilities Recognised In Business Combination 80.00K GBP.
- 2019-12-31: Contingent Liabilities Recognised In Business Combination 80.00K GBP.
- 2019-10-31: Contingent Liabilities Recognised In Business Combination 80.00K GBP.
- 2019-07-31: Contingent Liabilities Recognised In Business Combination 80.00K GBP.
| Period end | Contingent Liabilities Recognised In Business Combination |
|---|---|
| 2020-03-31 | 80.00K GBP 6-K · filed 2020-06-02 |
| 2019-12-31 | 80.00K GBP 6-K · filed 2020-06-02 |
| 2019-10-31 | 80.00K GBP 6-K · filed 2019-12-17 |
| 2019-07-31 | 80.00K GBP 6-K · filed 2019-10-11 |
| 2019-04-30 | 629.00K GBP 6-K · filed 2019-06-12 |
| 2019-01-31 | 629.00K GBP 20-F · filed 2020-04-30 |
| 2018-10-31 | 860.00K GBP 6-K · filed 2018-12-11 |
| 2018-01-31 | 0.00 GBP 20-F · filed 2020-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |